Issuer Information. Each Underwriter severally agrees that such Underwriter, without the prior written consent of the Partnership, has not used or referred to publicly and shall not use or refer to publicly any “free writing prospectus” (as defined in Rule 405) required to be filed by the Partnership with the Commission or retained by the Partnership under Rule 433, other than a free writing prospectus containing the information contained in the final term sheet prepared and filed pursuant to Section 5(b) of this Agreement; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule II hereto and any electronic road show. Any such free writing prospectus consented to by the Representatives or the Partnership is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Partnership agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
Issuer Information. Each Underwriter severally agrees that such Underwriter, without the prior written consent of the Partnership, has not used or referred to publicly and shall not use or refer to publicly any “free writing prospectus” (as defined in Rule 405 but excluding any Issuer Free Writing Prospectus identified on Schedule V hereto and any electronic road show constituting a free writing prospectus under Rule 433) required to be filed by the Partnership with the Commission or retained by the Partnership under Rule 433. Any such free writing prospectus consented to by the Representatives or the Partnership is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Partnership agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
Issuer Information. Such information as defined in Rule 433(h) under the Act and which shall not include information that is merely based on or derived from such information.
Issuer Information subscriber understands that True Leaf is subject to all the risks that apply to early-stage companies, whether or not those risks are explicitly set out in the offering circular.
Issuer Information. Fee is payable per Issuer irrespective of whether the Information is sourced from BHB or from a Distributor. If the Issuer is the Licensee, the Issuer is responsible for paying this fee but the License Fee is not applicable where the Licensee is already paying any Market Coverage Distribution License Fee or Enterprise License Fee. If the Issuer sources Issuer Information from Licensee, for example via a web-hosted display, the Licensee is responsible for reporting the Issuer and paying the respective Fee to BHB.
Issuer Information. The Issuer shall provide to any holder of a beneficial interest in any Note or any prospective purchaser of a Note or a beneficial interest therein, upon the request of such holder or prospective purchaser, the information regarding the Issuer required to be prepared by the Issuer pursuant to Rule 144A.
Issuer Information. Each Underwriter severally agrees that such Underwriter, without the prior written consent of the Partnership, has not used or referred to publicly and shall not use or refer to publicly any “free writing prospectus” (as defined in Rule 405 but excluding any Issuer Free Writing Prospectus identified on Schedule V hereto and any electronic road show constituting a free writing prospectus under Rule 433) in connection with the offer and sale of the Units; provided that no such consent shall be required with respect to any free writing prospectus filed by the Partnership with the Commission prior to the use of such free writing prospectus.
Issuer Information. See Section 8(a)(i) hereof. New Guarantees: See Section 2(a) hereof. Notes: See the introductory paragraphs hereto.
Issuer Information. The Borrower shall have provided the Bank with a copy of the most recent quarterly financial statements, including, at a minimum, a balance sheet and related statements of income, retained earnings and cash flows of the Issuer of the Stock to be purchased with the proceeds of such Revolving Loan at least ten (10) Business Days prior to the date of the making of such Revolving Loan and such Stock shall be acceptable to the Bank in its sole and absolute discretion.
Issuer Information. See Section 8(a)(i) hereof. Market-Maker: See Section 4(a) hereof. Market-Making Conditions: See Section 4(a) hereof.
